Chisato Makino

Title: Chisato Makino: Innovator in Antidiabetic Preparations

Introduction

Chisato Makino is a prominent inventor based in Kawasaki, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antidiabetic preparations. With a total of 6 patents to her name, her work has been instrumental in advancing treatment options for diabetes.

Latest Patents

Among her latest innovations is a nateglinide-containing preparation designed to be small-sized and easy to take. This preparation contains 26% or more of nateglinide and 28% or more of at least one disintegrant selected from a specific group, which includes carmellose or its salts, sodium carboxymethyl starch, croscarmellose sodium, crospovidone, partly pregelatinized starch, and low-substituted hydroxypropyl cellulose. The high content of nateglinide in this preparation allows for immediate absorption, thereby exhibiting a hypoglycemic action. Another notable patent is an immediate-release preparation that utilizes amorphous nateglinide as an active ingredient, further enhancing its effectiveness as an antidiabetic.

Career Highlights

Chisato Makino is associated with Ajinomoto Co., Ltd., a leading company in the food and pharmaceutical industries. Her work at Ajinomoto has allowed her to focus on innovative solutions for diabetes management, contributing to the company's reputation for excellence in research and development.

Collaborations

Throughout her career, Chisato has collaborated with esteemed colleagues, including Akira Yabuki and Nobutaka Ninomiya. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Chisato Makino's contributions to the field of antidiabetic preparations highlight her role as a key innovator in the pharmaceutical industry. Her patents reflect her commitment to improving the lives of individuals with diabetes through effective and accessible treatments.